Hodgkin Lymphoma Clinical Trials in Madison, Wisconsin

4 studies are recruiting for hodgkin lymphoma in Madison, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

    This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing).

    Stage
    Phase 1
    Ages
    18 to 100
    Site
    University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
    Locations
    7 in total
    Run by
    Marker Therapeutics, Inc.

    See if you can join NCT05798897 on ClinicalTrials.gov

  2. A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

    This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

    Stage
    Not phased
    Ages
    Any age
    Site
    University of Wisconsin - Madison, Madison, Wisconsin
    Locations
    142 in total
    Run by
    Center for International Blood and Marrow Transplant Research

    See if you can join NCT01351545 on ClinicalTrials.gov

  3. Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

    This is a Phase I/II, multicenter, open-label, dose escalation/dose-expansion study to evaluate the tolerability, safety, and the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma (cHL).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Wisconsin, Madison, Wisconsin
    Locations
    6 in total
    Run by
    Veronika Bachanova

    See if you can join NCT03681561 on ClinicalTrials.gov

  4. Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

    This phase I trial studies the safety of transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells in conjunction with the immunomodulating drug, Zoledronate, given in the post-transplant period to treat pediatric patients with relapsed or…

    Stage
    Phase 1
    Ages
    0 to 21
    Site
    University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
    Run by
    University of Wisconsin, Madison

    See if you can join NCT02508038 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.